Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

This publication has 21 references indexed in Scilit:

• Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
  Emerging Infectious Diseases, 1999
• Comparison of Activities of Broad-Spectrum β-Lactam Compounds against 1,128 Gram-Positive Cocci Recently Isolated in Cancer Treatment Centers
  Antimicrobial Agents and Chemotherapy, 1999
• The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
  Cancer, 1996
• Bacteremia due to viridans streptococci in neutropenic patients: A review
  The American Journal of Medicine, 1994
• Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk Factors
  Clinical Infectious Diseases, 1994
• The Changing Epidemiology of Infections at Cancer Hospitals
  Clinical Infectious Diseases, 1993
• Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors
  Clinical Infectious Diseases, 1992
• Bacterial Endocarditis at a Small Community Hospital
  The Lancet Healthy Longevity, 1990
• Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with Cancer
  New England Journal of Medicine, 1988
• Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
  Annals of Internal Medicine, 1966